Cyclo Therapeutics

$7.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.38 (-4.85%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CYTH and other stocks, options, and ETFs commission-free!

About CYTH

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product candidates include Trappsol Cyclo, which treats Neimann-Pick Type C disease. The firm focuses on the development and commercialization of innovative cyclodextrin-based products for the treatment of people with serious and life threatening rare diseases and medical conditions. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL. The listed name for CYTH is Cyclo Therapeutics, Inc. Common Stock.

CEO
Nathan Scott Fine
Employees
8
Headquarters
Gainesville, Florida
Founded
1990
Market Cap
35.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
258.50K
High Today
$8.10
Low Today
$6.50
Open Price
$8.04
Volume
349.23K
52 Week High
$990.00
52 Week Low
$3.40

You May Also Like

PGR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure